Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma

BACKGROUND: The prevalence of non‐B or non‐C hepatocellular carcinoma (NBNC‐HCC) has been increasing all over the world. Advanced glycation end products (AGE) play a role in the pathogenesis of alcoholic liver injury or nonalcoholic steatohepatitis (NASH). METHODS: We examined here whether serum lev...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Lab Anal
Main Authors: Kan, Hiromi, Yamagishi, Sho‐ichi, Ojima, Ayako, Fukami, Kei, Ueda, Seiji, Takeuchi, Masayoshi, Hyogo, Hideyuki, Aikata, Hiroshi, Chayama, Kazuaki
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2014
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807017/
https://ncbi.nlm.nih.gov/pubmed/25252033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21797
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares